First and only fully validated industrial scale plant cell technology platform for the production of plant metabolites

Our Values

  • Science

    We do not make any claims that are not scientifically based. They are either backed by published and renowed scientific research, or supported by clinical trials.

  • Sustainability

    We make sure every step of our process is consistent with eco-friendliness and the preservation of nature. As such, we use only 1% of the same land required to produce metabolites. We are NON GMO, and pesticide-free.

  • Regulatory compliance

    We respect all rules and regulations and adhere to them rigorously. We employ the highest standards including ISO and GMP.

  • Customer first

    Human health is our grand motivator, and we strive to produce wellness products that are scientifically proven with a first class customer service.

  • Employee’s satisfaction

    Our employees are our most valued asset and we treat them with the highest respect and provide them with the best working and safest conditions.

Executive Team

  • Ilan Sobel
    CEO

    Ilan Sobel, brings to the Company extensive experience in General Management, International Sales and Marketing, Manufacturing and Operations. For the past 6 years, Ilan served as Chief Operating Officer and transitioned to Chief Commercial Officer of Weissbeerger for the last 2 years. In this capacity, Ilan played a major leadership role in building a disruptive BIG Data, IOT & Software Company servicing major Beverage players which was recently purchased by Anheuser Busch InBev. Previously, Ilan served an 18 year stint as an International Employee of The Coca-Cola Company, where he played a pivotal role in key senior leadership positions generating significant revenue and profit growth and improving brand health trends across diverse global markets including the United States, China, Hong Kong, Taiwan, Thailand, Singapore, Malaysia, Vietnam, the Philippines and South Africa. Ilan brings to BioHarvest Sciences a wealth of hands-on experience, business acumen and leadership expertise in building large-scale businesses and billion-dollar brands , including a very strong ability to access C level executives at top Fast-Moving Consumer Goods Companies & National Retailers

  • Yochi Hagay
    CTO

    Dr. Yochi Hagay, Ph.D., is the company’s CTO and CTO of BioHarvest Ltd and formerly served as Chief Executive Officer of BioHarvest. She has an extensive experience in leading research and development in the pharmaceutical and bio-tech industry. Prior to co-founding BioHarvest in 2005, Ms. Hagay served as the Managing Partner at Zaki Rakib’s Bio-Tech Capital Venture. During that time, she evaluated a large number of scientific research projects and bio-tech companies. Ms. Hagay has served in various positions in BTG for 15 years, until it was acquired by Savient. In her most recent role at Savient (2002-2005), she supervised the company’s clinical studies. Ms. Hagay holds a PhD in biotechnology from Hebrew University (2004).

  • Zaki Rakib
    President and Chairman of the Board

    Dr. Zaki Rakib, Ph.D., serves as the President and Chairman of BioHarvest. He has extensive experience within the software, telecommunications hardware, semiconductors, cellular operations and bioscience categories, where he has spearheaded the development of multiple cutting-edge innovations. Leveraging his foundation in technical sciences, Dr. Rakib was one of the first leaders in the telecommunications industry after the company he co-founded Terayon Communication Systems, invented the first cable modem, and S-CDMA technology. Dr. Rakib holds a Bachelor of Science (1978), a Master of Science (1981), and a Ph.D. degree in Engineering (1984) from Ben-Gurion University in Israel.

  • Malkit Azachi
    VP R&D

    Dr. Azachi brings nearly 20 years of experience in biochemistry, genetic engineering, tissue culture, molecular biology, and clinical & pre-clinical trials. Prior to BioHarvest, Dr. Azachi served as technology Director at HealOrLtd, a Biopharmaceutical company developing topical therapeutics. Prior to that, Dr. Azachi lead product development at the research and development department of ColbarLifeScience, a Johnson & Johnson Company. Before that Dr.Azachi lead cartilage regeneration product and bone substitute development for Prochon Biotech; and immunotherapy related development for Omrix Biopharmaceuticals -acquired by Johnson & Johnson. Dr. Azachi holds a Ph.Din microbiology from the Hebrew University of Jerusalem and a Post-Doc in Molecular Biology of the cell from Weizmann Institute of Science.

  • Eitan Popper
    Chairman of the Board of Advisors

    Mr. Popper was the co-founder and President of MedReleaf Corp., which was acquired in 2018 for $2.5 billion USD, in what is considered the largest Cannabis industry exit to date. Prior to its acquisition, MedReleaf was one of the largest and most reputable vertically integrated medical Cannabis producers in the world. Mr. Popper brings over 15 years of international partnerships, entrepreneurial ventures, disruptive industry, large-scale project development, engineering and investment experience. Mr. Popper holds a B.Sc. in Civil Engineering from the UIA in Mexico, a M.Sc. in Environmental Fluid Mechanics from Stanford University, and an MBA from the Recanati School of Business at Tel Aviv University.

  • Michal Sapir
    VP Regulation Affairs

    Michal joined BioHarvest in 2010 and brings 30 years of experience in medical device, pharma and biotechnology industries. She is responsible for the regulatory pathways & strategy for the Company, registration of Company products (food and dietary supplement), the communication with the regulatory authorities and establishment of the Company QA Systems. Before joining BioHarvest Michal served as the Director of Project Management in ColBar LifeScience Ltd., Johnson & Johnson Company (2001-2010). As part of the ColBar management team, she led complex projects in medical device development and planning and managing annual multidisciplinary work plans. Prior to that Michal gained broad experience in clinical and animal studies; she served as Affiliate Quality Coordinator & Senior Clinical Research Administrator in Eli Lilly (1995-2000). Earlier in her career she gained experience in Pharmacological and Toxicological animal studies at the Biological Research Company (1987-1995) Michal holds a Master of Science in biochemistry from Bar Ilan University

  • Alan Rootenberg
    CFO

    Mr. Alan Rootenberg, the company’s CFO, is a chartered professional accountant who has served as the Chief Financial Officer of a number of publicly traded companies, listed on the TSX, TSXV, CSE and OTCBB. Alan has a Bachelor of Commerce degree and received his CPA designation in Ontario, Canada. His extensive experience includes serving as Chief Financial Officer for mineral exploration, mining, technology and medical cannabis companies. Mr. Rootenberg holds a Certificate in the Theory of Accounting from University of Witwatersrand (1977), a bachelor’s degree in commerce from University of Witwatersrand (1975) and was registered as a CPA in 1980.

  • Justin Meiklem
    IR Consultant

    Justin has worked in the cutting edge of technology and internet marketing since 2004, . From 2014 to early 2020, Justin led all Marketing and Sales for Stockhouse Publishing, growing it into one of the world’s largest investment communities. That tenure culminated in the successful 2019 sale of Stockhouse.com for over $20 million. Justin brings expertise with marketing planning, shareholder acquisition, and investor communication, and he deep has deep connections throughout the capital markets, including the top retail investor targeted service providers in the capital markets.

Board of Directors

  • Vivien Rakib

    Vivien Rakib, the company’s Director, has served as a director of BioHarvest since 2007. Ms. Rakib worked in software development in Silicon Valley for 18 years. She is currently an active technology start-up investor and serves on several NGO board of directors. Ms. Rakib holds a B.Sc. in Mathematics and Computer Science from of Ben Gurion University in Israel.

  • David Ryan

    Mr. David Ryan the company’s President, Secretary and Director VP of Investor Relations, has extensive experience in investment and public markets. For the past 20 years, he has been part of in bringing multiple initial public offerings to market. He has helped raise both equity and debt financings for numerous public companies in both primary and secondary financings as well as served on the board of public companies and in various roles from president to director. Mr. Ryan is a member of the company’s Audit Committee.

  • Jake Fiddick

    Mr. Jake Fiddick, the company’s Director, founded the “Public Company Banking Group” for Bank of Montreal (“BMO”) in 1984 and was part of a tight-knit 15-person team specializing in servicing public companies. He retired in August 2017. During his 58 years with BMO he obtained his real estate license, and broker’s license. Mr. Fiddick is a member of the company’s Audit Committee.

  • Liron Carmel

    Mr. Liron Carmel, the company’s Director, was the Chairman and CEO of Emerald Medical Applications Corp from December 2014 to August 2015. He is currently the Chairman and CEO of Smart Energy Solutions Inc. since November 2011. Mr. Carmel is a member of the company’s Audit Committee.

  • Zaki Rakib

    Dr. Zaki Rakib, Ph.D., serves as the President and Chairman of BioHarvest. He has extensive experience within the software, telecommunications hardware, semiconductors, cellular operations and bioscience categories, where he has spearheaded the development of multiple cutting-edge innovations. Leveraging his foundation in technical sciences, Dr. Rakib was one of the first leaders in the telecommunications industry after the company he co-founded Terayon Communication Systems, invented the first cable modem, and S-CDMA technology. Dr. Rakib holds a Bachelor of Science (1978), a Master of Science (1981), and a Ph.D. degree in Engineering (1984) from Ben-Gurion University in Israel.